Eton Pharmaceuticals (ETON) Gross Profit (2019 - 2025)

Eton Pharmaceuticals (ETON) has 7 years of Gross Profit data on file, last reported at $13.1 million in Q4 2025.

• For the quarter ending Q4 2025, Gross Profit rose 102.29% year-over-year to $13.1 million; the trailing twelve-month figure through Dec 2025 stood at $42.7 million (up 82.56% YoY), and the FY2025 full-year result was $42.7 million, up 82.56% from the prior year.
• Gross Profit improved to $13.1 million in Q4 2025, from $7.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $13.1 million in Q4 2025 to a low of $121000.0 in Q3 2021.
• A 5-year average of $6.0 million and a median of $5.7 million in 2021 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit jumped 343666.67% in 2021 and sank 87.13% in 2022, its largest moves.
• Tracing ETON's Gross Profit over 5 years: stood at $5.7 million in 2021, then grew by 11.17% to $6.4 million in 2022, then slumped by 42.92% to $3.6 million in 2023, then soared by 78.4% to $6.5 million in 2024, then surged by 102.29% to $13.1 million in 2025.
• Business Quant data shows ETON's Gross Profit at $13.1 million in Q4 2025, $7.9 million in Q3 2025, and $11.9 million in Q2 2025.